308 related articles for article (PubMed ID: 20062081)
21. Genetic modification does not affect the stemness of neural stem cells in nestin promoter-GFP transgenic mice.
Park JH; Ahn JI; Kim SY; Park KS; Lee YD; Yamaguchi M; Chung HJ
Neurosci Lett; 2007 Jun; 421(3):185-90. PubMed ID: 17574339
[TBL] [Abstract][Full Text] [Related]
22. Musashi1 modulates cell proliferation genes in the medulloblastoma cell line Daoy.
Sanchez-Diaz PC; Burton TL; Burns SC; Hung JY; Penalva LO
BMC Cancer; 2008 Sep; 8():280. PubMed ID: 18826648
[TBL] [Abstract][Full Text] [Related]
23. [Subtypes of medulloblastomas: distinct cellular origins].
Bourdeaut F; Pouponnot C; Ayrault O
Med Sci (Paris); 2012 Oct; 28(10):805-9. PubMed ID: 23067406
[No Abstract] [Full Text] [Related]
24. Cerebellar granule cells: insights into proliferation, differentiation, and role in medulloblastoma pathogenesis.
Behesti H; Marino S
Int J Biochem Cell Biol; 2009 Mar; 41(3):435-45. PubMed ID: 18755286
[TBL] [Abstract][Full Text] [Related]
25. Differential forms of p53 in medulloblastoma primary tumors, cell lines and xenografts.
Philipova T; Baryawno N; Hartmann W; Pietsch T; Druid H; Johnsen JI; Ekström TJ
Int J Oncol; 2011 Mar; 38(3):843-9. PubMed ID: 21184030
[TBL] [Abstract][Full Text] [Related]
26. Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.
Fan X; Matsui W; Khaki L; Stearns D; Chun J; Li YM; Eberhart CG
Cancer Res; 2006 Aug; 66(15):7445-52. PubMed ID: 16885340
[TBL] [Abstract][Full Text] [Related]
27. The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells.
Lawinger P; Venugopal R; Guo ZS; Immaneni A; Sengupta D; Lu W; Rastelli L; Marin Dias Carneiro A; Levin V; Fuller GN; Echelard Y; Majumder S
Nat Med; 2000 Jul; 6(7):826-31. PubMed ID: 10888935
[TBL] [Abstract][Full Text] [Related]
28. OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas.
de Haas T; Oussoren E; Grajkowska W; Perek-Polnik M; Popovic M; Zadravec-Zaletel L; Perera M; Corte G; Wirths O; van Sluis P; Pietsch T; Troost D; Baas F; Versteeg R; Kool M
J Neuropathol Exp Neurol; 2006 Feb; 65(2):176-86. PubMed ID: 16462208
[TBL] [Abstract][Full Text] [Related]
29. Identification of a novel homozygous deletion region at 6q23.1 in medulloblastomas using high-resolution array comparative genomic hybridization analysis.
Hui AB; Takano H; Lo KW; Kuo WL; Lam CN; Tong CY; Chang Q; Gray JW; Ng HK
Clin Cancer Res; 2005 Jul; 11(13):4707-16. PubMed ID: 16000565
[TBL] [Abstract][Full Text] [Related]
30. Bmi1 overexpression in the cerebellar granule cell lineage of mice affects cell proliferation and survival without initiating medulloblastoma formation.
Behesti H; Bhagat H; Dubuc AM; Taylor MD; Marino S
Dis Model Mech; 2013 Jan; 6(1):49-63. PubMed ID: 23065639
[TBL] [Abstract][Full Text] [Related]
31. Medulloblastoma.
Katsetos CD; Burger PC
Semin Diagn Pathol; 1994 May; 11(2):85-97. PubMed ID: 7809510
[TBL] [Abstract][Full Text] [Related]
32. Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medulloblastoma.
Shimato S; Natsume A; Takeuchi H; Wakabayashi T; Fujii M; Ito M; Ito S; Park IH; Bang JH; Kim SU; Yoshida J
Gene Ther; 2007 Aug; 14(15):1132-42. PubMed ID: 17508009
[TBL] [Abstract][Full Text] [Related]
33. PTEN Signaling in the Postnatal Perivascular Progenitor Niche Drives Medulloblastoma Formation.
Zhu G; Rankin SL; Larson JD; Zhu X; Chow LM; Qu C; Zhang J; Ellison DW; Baker SJ
Cancer Res; 2017 Jan; 77(1):123-133. PubMed ID: 27815386
[TBL] [Abstract][Full Text] [Related]
34. Medulloblastoma stem cells: modeling tumor heterogeneity.
Manoranjan B; Venugopal C; McFarlane N; Doble BW; Dunn SE; Scheinemann K; Singh SK
Cancer Lett; 2013 Sep; 338(1):23-31. PubMed ID: 22796365
[TBL] [Abstract][Full Text] [Related]
35. Bax deficiency prolongs cerebellar neurogenesis, accelerates medulloblastoma formation and paradoxically increases both malignancy and differentiation.
Garcia I; Crowther AJ; Gama V; Miller CR; Deshmukh M; Gershon TR
Oncogene; 2013 May; 32(18):2304-14. PubMed ID: 22710714
[TBL] [Abstract][Full Text] [Related]
36. Somatic cell transfer of c-Myc and Bcl-2 induces large-cell anaplastic medulloblastomas in mice.
Jenkins NC; Rao G; Eberhart CG; Pedone CA; Dubuc AM; Fults DW
J Neurooncol; 2016 Feb; 126(3):415-24. PubMed ID: 26518543
[TBL] [Abstract][Full Text] [Related]
37. FOXG1 expression shows correlation with neuronal differentiation in cerebellar development, aggressive phenotype in medulloblastomas, and survival in a xenograft model of medulloblastoma.
Adesina AM; Veo BL; Courteau G; Mehta V; Wu X; Pang K; Liu Z; Li XN; Peters L
Hum Pathol; 2015 Dec; 46(12):1859-71. PubMed ID: 26433703
[TBL] [Abstract][Full Text] [Related]
38.
Tao R; Murad N; Xu Z; Zhang P; Okonechnikov K; Kool M; Rivero-Hinojosa S; Lazarski C; Zheng P; Liu Y; Eberhart CG; Rood BR; Packer R; Pei Y
Cancer Res; 2019 Apr; 79(8):1967-1980. PubMed ID: 30862721
[TBL] [Abstract][Full Text] [Related]
39. Lack of Rb and p53 delays cerebellar development and predisposes to large cell anaplastic medulloblastoma through amplification of N-Myc and Ptch2.
Shakhova O; Leung C; van Montfort E; Berns A; Marino S
Cancer Res; 2006 May; 66(10):5190-200. PubMed ID: 16707443
[TBL] [Abstract][Full Text] [Related]
40. Null mutation of DNA strand break-binding molecule poly(ADP-ribose) polymerase causes medulloblastomas in p53(-/-) mice.
Tong WM; Ohgaki H; Huang H; Granier C; Kleihues P; Wang ZQ
Am J Pathol; 2003 Jan; 162(1):343-52. PubMed ID: 12507917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
